Navigation Links
Samsung Medison Pledges to Become a World-Class Medical Device Company
Date:5/9/2011

CYPRESS, Calif., May 9, 2011 /PRNewswire/ -- Medison and Samsung Electronics jointly announced a new corporate identity of Samsung Medison. The combined company, a joint partnership between Korea's leading diagnostic ultrasound equipment manufacturer and one of the world's largest and most technologically-advanced electronics and consumer goods companies, has outlined a new vision of transforming itself into a global leader in medical device industry.

Mr. Sang-Won Bang, CEO of Samsung Medison, launched the new corporate vision of 'New Vision into Life', and announced company's goal of becoming one of the world's top 4 diagnostic ultrasound firms. Samsung Medison aims to become a world's best medical equipment manufacturer by 2020.

Mr. Bang added, "With a launch of the new corporate name, Samsung Medison, we will put customer satisfaction at the top of our priority list by providing the very best in quality and service, in line with Samsung's global image. We will dramatically increase our investment in research and development, and will do our best to promote human health and happiness by securing the best in scientific and human resources in the medical device industry."

Samsung Medison will combine Samsung's resources, digital technology and experience of growth worldwide with Medison's technological prowess and established market presence. The company will continue to invest more than 10% of its annual sales in R&D, and will expand investment in marketing strategies such as holding global academic conferences and seminars. In addition, Samsung plans to have more than 10,000 employees in its medical equipment business by 2020.

About Samsung Medison

Samsung Medison is Korea's leading diagnostic ultrasound company. Founded in 1985, the company is now selling cutting-edge medical devices in 110 countries around the world, with some 85% of its sales coming from outside of Korea. The company has attracted global attention in the medical device community by developing its own technology through its advanced R&D capabilities, and by propelling major advances such as producing the world's first commercially-available 3D ultrasound product. The company has also introduced many other advanced products, ranging from its signature 'Accuvix' and 'SonoAce' series, to a laptop-sized ultra-compact diagnostic ultrasound system.

In February 2011, Samsung became a majority shareholder of Samsung Medison. For more information visit, www.samsungmedison.com


'/>"/>
SOURCE Samsung Medison America
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. American Association for Homecare Proposes Strong Anti-Fraud Measures in Medicare, Applauds HHS Testimony Today That Pledges to "Stop Fraud Before it Starts"
2. Dominos Pizza Pledges Support to the Fifth Annual St. Jude Childrens Research Hospital(R) Thanks and Giving(R) Campaign
3. Hillary Clinton Pledges Bold Approach to Stopping HIV/AIDS & Global Poverty
4. PLC Systems Chief Financial Officer to Leave Company to Become CEO of Clinquest
5. PharMEDium Becomes a Corporate Supporter of the American Society of Anesthesiologists (ASA)
6. Stray Energy Burns Become a "Hot Topic" in Recent Publications
7. Detroit Medical Center Becomes First in Southeast Michigan to Study an Implantable Device, Designed to Reduce Patient Time to the ER and Improve Survival Rates From Heart Attack in High-Risk Patients
8. One-for-10 Reverse Stock Split of Insmed Common Stock Becomes Effective
9. Roche Teams with Womack Army Medical Center to Become First IVD Manufacturer approved for Remote Network Connectivity with DOD
10. Zimmer Continuum® Acetabular System Becomes Zimmers Best Selling Hip Construct
11. Fred Funk Becomes Spokesperson for Stryker Orthopaedics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology:
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... June ... about the dangers associated with chronic pain and the benefits of holistic treatments, ... individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
Breaking Medicine News(10 mins):